Skip to content
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Hematology

How to Manage Heavy Periods with Glanzmann Thrombasthenia

At a Glance

Managing heavy periods with Glanzmann Thrombasthenia requires a coordinated approach using continuous hormonal birth control, tranexamic acid to stabilize clots, and iron therapy for anemia. Never use NSAIDs for cramps, as they worsen bleeding risk. Seek immediate care for severe blood loss.

For individuals with Glanzmann Thrombasthenia (GT), managing extremely heavy periods (menorrhagia) requires a coordinated effort between a hematologist and a gynecologist [1][2]. The most effective strategy typically involves continuous hormonal birth control to suppress or lighten periods, antifibrinolytic medications like tranexamic acid to stabilize blood clots, and aggressive iron supplementation to prevent severe anemia [3][4][5]. Because GT prevents platelets from clumping together normally, heavy menstrual bleeding is one of the most debilitating daily symptoms, but it can be managed effectively with the right medical interventions [6].

Suppressing Bleeding with Hormonal Therapy

Hormonal therapy is considered a primary, first-line medical intervention for managing heavy menstrual bleeding in GT [7][5]. Instead of treating the bleeding once it starts, continuous hormonal therapies aim to suppress menstruation altogether or make the cycles significantly lighter [8][9].

Common hormonal options include:

  • Combined oral contraceptives (The Pill): Often taken continuously (skipping the placebo pills) to prevent periods entirely [5].
  • Depot medroxyprogesterone acetate (Depo-Provera): Injections given every few months, which have shown remarkable improvement in managing heavy periods [7]. Note: Because standard intramuscular (IM) injections carry a high risk of deep muscle bleeding (hematomas) in GT patients, subcutaneous (under-the-skin) formulations or specialized precautions are required.
  • Levonorgestrel-releasing intrauterine systems (LNG-IUS): Hormonal IUDs that thin the uterine lining over time. While highly effective for heavy bleeding, inserting an IUD in someone with GT carries a risk of procedural bleeding and requires specialized hematological preparation prior to insertion [10][11].

Stabilizing Clots and Managing Pain Safely

While hormonal therapy addresses the uterine lining, antifibrinolytic medications work to keep blood clots from breaking down too quickly. Tranexamic acid (Lysteda) is considered a standard therapy for preventing excessive menstrual bleeding in patients with GT [12]. It is typically taken orally during the days of heaviest flow [13].

However, tranexamic acid must be used with care under a doctor’s supervision [14]. Over-aggressive use of antifibrinolytics in GT patients has occasionally been associated with adverse effects, such as acrocyanosis (a condition where the hands and feet turn blue due to poor circulation) [14].

Crucial Warning on Pain Relief: Heavy periods often bring painful cramps. Do not use NSAIDs (Non-Steroidal Anti-Inflammatory Drugs like ibuprofen, Advil, Motrin, or Aleve). NSAIDs further interfere with platelet function and can trigger dangerous bleeding in GT patients. Always use acetaminophen (Tylenol) or other pain relievers specifically approved by your hematologist.

Preventing and Treating Iron Deficiency Anemia

Chronic, recurrent blood loss from heavy periods frequently leads to Iron deficiency anemia (IDA), a serious complication that causes fatigue, weakness, and decreased quality of life [15][16]. Regular monitoring of your iron and hemoglobin levels is essential [17].

Because oral iron pills may not be sufficient to keep up with chronic menstrual blood loss, many GT patients require intravenous (IV) iron infusions [18]. IV iron formulations, such as ferric carboxymaltose, can rapidly increase hemoglobin levels, reduce emergency hospital visits, and significantly improve quality of life when oral supplements fail or cause severe stomach upset [18].

Options for Severe or Emergency Bleeding

If you are soaking through a pad or tampon every hour for two consecutive hours, or experiencing signs of severe blood loss like dizziness, shortness of breath, or a racing heart, seek emergency medical care immediately.

In cases where medical management fails or bleeding becomes an emergency, doctors must intervene [19][20]. The go-to emergency hemostatic agent is Recombinant activated factor VII (rFVIIa), an IV medication administered in a hospital or clinic, which is safely and effectively used to control acute, severe menstrual bleeding [5][21][22].

While platelet transfusions can also stop bleeding, doctors often use rFVIIa to avoid alloimmunization [23]. Alloimmunization occurs when the body’s immune system develops antibodies against donor platelets, rendering future platelet transfusions ineffective (refractoriness) [24][25]. For this reason, treatments like rFVIIa are vital alternatives [26].

Common questions in this guide

Do Glanzmann Thrombasthenia Carriers Have Bleeding Symptoms?Does Glanzmann Thrombasthenia Shorten Life Expectancy?Does Type 1 Glanzmann Thrombasthenia Mean Worse Bleeding?How Does Glanzmann Thrombasthenia Differ From HemophiliaHow Rare is Glanzmann Thrombasthenia? Prevalence & FactsHow to Stop Severe Nosebleeds with GTWill I Pass Glanzmann Thrombasthenia to My Baby?Is There a Cure for Glanzmann Thrombasthenia? ExplainedCan You Have a Baby With Glanzmann Thrombasthenia?What Sports Are Safe for Glanzmann Thrombasthenia?What to Include in a GT Emergency LetterWhy Avoid NSAIDs With Glanzmann Thrombasthenia?Why Avoid Platelet Transfusions in GT?Why Do Blood Tests Miss Glanzmann Thrombasthenia?How to Manage Dental Surgery with Glanzmann Thrombasthenia
What are the best birth control options for managing heavy periods with Glanzmann Thrombasthenia?
Continuous combined oral contraceptives and specialized hormonal injections or IUDs are highly effective for suppressing periods in GT patients. Because of procedural bleeding risks, IUD insertion requires careful preparation with a hematologist.
Is it safe to take NSAIDs like ibuprofen for menstrual cramps if I have GT?
No, you should never use NSAIDs like ibuprofen or naproxen if you have Glanzmann Thrombasthenia. These medications interfere with platelet function and can trigger dangerous bleeding. Always use acetaminophen or other pain relievers specifically approved by your hematologist.
How does tranexamic acid help with heavy menstrual bleeding?
Tranexamic acid is an antifibrinolytic medication that prevents blood clots from breaking down too quickly. It is commonly taken as an oral pill during the heaviest days of your period to significantly reduce blood loss.
Why might I need IV iron instead of iron pills for heavy periods?
Chronic heavy periods frequently cause severe iron deficiency anemia. Intravenous (IV) iron infusions can raise your hemoglobin levels much faster than oral pills, especially if oral supplements cause severe stomach upset or fail to keep up with chronic blood loss.
What should I do if I am experiencing an unusually heavy period or severe blood loss?
If you soak through a pad or tampon every hour for two consecutive hours, or feel dizzy and short of breath, seek emergency medical care immediately. Doctors can use emergency intravenous treatments like recombinant activated factor VII to safely stop severe bleeding.

Questions for Your Doctor

5 questions

  • How can we ensure seamless communication between my hematologist and gynecologist when adjusting my menstrual management plan?
  • What are my specific hemoglobin and ferritin goals, and how often should I have blood tests to monitor for anemia?
  • If we proceed with an IUD insertion or another procedure, what specific hemostatic medications will I receive beforehand to prevent bleeding?
  • Are my current pain relievers for menstrual cramps safe for someone with Glanzmann Thrombasthenia?
  • Do I have any anti-platelet or anti-HLA antibodies that would prevent platelet transfusions from working in an emergency?

Questions for You

4 questions

  • Have I been tracking the number of pads or tampons I go through on my heaviest days to accurately share my bleeding volume with my doctor?
  • Have I experienced symptoms of anemia lately, such as feeling unusually exhausted, short of breath, or dizzy?
  • Are my menstrual cramps currently managed with safe medications (like acetaminophen), or do I need a better pain relief plan?
  • How is the heaviness and unpredictability of my periods affecting my daily life, mental health, work, or school?

References

References (26)
  1. 1

    Heavy Menstrual Bleeding as a Common Presenting Symptom of Rare Platelet Disorders: Illustrative Case Examples.

    Rajpurkar M, O'Brien SH, Haamid FW, et al.

    Journal of pediatric and adolescent gynecology 2016; (29(6)):537-541 doi:10.1016/j.jpag.2016.02.002.

    PMID: 26876967
  2. 2

    Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric/neonatal and women's health SSCs.

    Zia A, Kouides P, Khodyakov D, et al.

    Journal of thrombosis and haemostasis : JTH 2020; (18(10)):2759-2774 doi:10.1111/jth.14974.

    PMID: 32573942
  3. 3

    Management of Severe Menorrhagia in an Adolescent with Glanzmann Thrombasthenia: A Case Report and Treatment Approach.

    Tiwari SK, Sonowal R, Bhowmick R, Joshi P

    Journal of pediatric and adolescent gynecology 2026; (39(2)):253-257 doi:10.1016/j.jpag.2025.11.008.

    PMID: 41265828
  4. 4

    Use of rFVIIa in Preventing Recurrent Intra-articular Hemorrhages in a 15-Year-Old Patient With Glanzmann Thrombasthenia.

    Laguna P

    Journal of pediatric hematology/oncology 2021; (43(8)):e1120-e1123 doi:10.1097/MPH.0000000000002105.

    PMID: 33625096
  5. 5

    Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.

    Kadowaki S, Makino S, Mohri Y, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2021; (32(2)):155-158 doi:10.1097/MBC.0000000000000977.

    PMID: 33196513
  6. 6

    How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults.

    Grainger JD, Thachil J, Will AM

    British journal of haematology 2018; (182(5)):621-632 doi:10.1111/bjh.15409.

    PMID: 30117143
  7. 7

    Glanzmann's thrombasthenia: a rare bleeding disorder in a Nigerian girl.

    Ezenwosu OU, Chukwu BF, Uwaezuoke NA, et al.

    African health sciences 2020; (20(2)):753-757 doi:10.4314/ahs.v20i2.27.

    PMID: 33163040
  8. 8

    Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis.

    Oliveira JA, Eskandar K, Chagas J, et al.

    Contraception 2024; (135()):110450 doi:10.1016/j.contraception.2024.110450.

    PMID: 38614274
  9. 9

    Tranexamic acid for management of heavy vaginal bleeding: barriers to access and myths surrounding its use.

    VanderMeulen H, Tang GH, Sholzberg M

    Research and practice in thrombosis and haemostasis 2024; (8(3)):102389 doi:10.1016/j.rpth.2024.102389.

    PMID: 38623473
  10. 10

    Oral invasive procedures in Glanzmann thrombasthenia: a retrospective observational study.

    Delarue M, Severac F, Soell M, et al.

    Research and practice in thrombosis and haemostasis 2024; (8(8)):102619 doi:10.1016/j.rpth.2024.102619.

    PMID: 39660077
  11. 11

    Perioperative Hemostatic Management of a Pediatric Patient with Glanzmann Thrombasthenia Undergoing Osteoplastic Craniotomy and Hematoma Removal: A Case Report.

    Lee SM, Kim KN, Kim SY

    Acta haematologica 2019; (142(4)):244-248 doi:10.1159/000499362.

    PMID: 31085914
  12. 12

    Glanzmann's Thrombastenia: The Role of Tranexamic Acid in Oral Surgery.

    Franco R, Miranda M, Di Renzo L, et al.

    Case reports in dentistry 2018; (2018()):9370212 doi:10.1155/2018/9370212.

    PMID: 30254767
  13. 13

    Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review.

    Ockerman A, Vanassche T, Garip M, et al.

    Thrombosis journal 2021; (19(1)):54 doi:10.1186/s12959-021-00303-9.

    PMID: 34380507
  14. 14

    Lessons Learned: Deformity Correction and Tibiotalocalcaneal Arthrodesis in a Patient With Glanzmann Thrombasthenia: A Case Report.

    Lam K, Janney C, Panchbhavi V

    JBJS case connector 2020; (10(1)):e0277 doi:10.2106/JBJS.CC.19.00277.

    PMID: 32044772
  15. 15

    Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis.

    Lee A, Maier CL, Batsuli G

    Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(4)):633-641 doi:10.1111/hae.14559.

    PMID: 35412688
  16. 16

    Double jeopardy, glomangiopericytoma and Glanzmann thrombasthenia resulting in recurrent epistaxis: a case report.

    Hammami E, Fath L, Debry C, Desprez D

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2024; (35(2)):62-65 doi:10.1097/MBC.0000000000001272.

    PMID: 38179703
  17. 17

    Hemorrhage of Upper Digestive and Respiratory Tracts in a Child with Glanzmann Thrombasthenia.

    Michali M, Basiari L, Komnos I, et al.

    Maedica 2023; (18(2)):363-367 doi:10.26574/maedica.2023.18.2.363.

    PMID: 37588843
  18. 18

    Ferric carboxymaltose for sub-acute and chronic iron deficiency anemia in inherited platelet function defects.

    Scaramellini N, Capecchi M, Artoni A, et al.

    Internal and emergency medicine 2021; (16(2)):505-507 doi:10.1007/s11739-020-02478-x.

    PMID: 32845453
  19. 19

    The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.

    Di Minno G, Zotz RB, d'Oiron R, et al.

    Haematologica 2015; (100(8)):1031-7 doi:10.3324/haematol.2014.121475.

    PMID: 26001793
  20. 20

    Surgical treatment of fibroids in heavy menstrual bleeding.

    Saridogan E

    Women's health (London, England) 2016; (12(1)):53-62 doi:10.2217/whe.15.89.

    PMID: 26693796
  21. 21

    The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.

    Poon MC

    Thrombosis and haemostasis 2021; (121(3)):332-340 doi:10.1055/s-0040-1718373.

    PMID: 33124022
  22. 22

    The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.

    Poon MC, d'Oiron R, Zotz RB, et al.

    Haematologica 2015; (100(8)):1038-44 doi:10.3324/haematol.2014.121384.

    PMID: 26001792
  23. 23

    Immune gene polymorphisms associated with poor response to platelet transfusion and recombinant factor VII administration in Glanzmann thrombasthenia.

    Naderi M, Mirzaei I, Seidizadeh O, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2024; (30(3)):752-764 doi:10.1111/hae.14971.

    PMID: 38439143
  24. 24

    Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.

    Di Minno G

    Blood reviews 2015; (29 Suppl 1()):S26-33.

    PMID: 26073366
  25. 25

    Outcomes of recombinant activated factor VIIa (NovoSeven) therapy in glanzmann thrombasthenia: two case reports.

    Almatar E, Alsharidah S, Hashem OA

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2025; (36(6)):293-295 doi:10.1097/MBC.0000000000001380.

    PMID: 40673721
  26. 26

    New Insights Into the Treatment of Glanzmann Thrombasthenia.

    Poon MC, Di Minno G, d'Oiron R, Zotz R

    Transfusion medicine reviews 2016; (30(2)):92-9.

    PMID: 26968829

This page provides educational information about managing menstrual bleeding with Glanzmann Thrombasthenia. Always consult your hematologist and gynecologist before starting any new medications, pain relievers, or procedures.

Get notified when new evidence is published on Glanzmann Thrombasthenia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.